The US inhalable drug market is anticipated to grow at a CAGR of 2.3% during the forecast period (2020-2026). The key factors driving the growth of the market include the rising prevalence of various respiratory and non- respiratory diseases in the country. The prevalence of asthma in the US is 1 in every 13 people. Over 25 million Americans are likely to have asthma, as of 2018, representing 7.7% of adults and 8.4% of children. Other factors that fuel the market growth in the country is increasing geriatric population and availability of a wide range of treatment option to choose from. Besides, a sedentary lifestyle along with unhealthy eating habits such as smoking, which is a prime factor for the increasing prevalence of several respiratory diseases such as COPD and asthma. The aforementioned factors create demand for inhalable drugs and hence drives the growth of the market in the country.

Request a free sample of our report on US Inhalable Drugs Market: https://www.omrglobal.com/request-sample/us-inhalable-drugs-market

The US inhalable drug market has been segmented on the basis of the application and route of administration. Based on the application, the market is bifurcated into respiratory disease and non-respiratory diseases. The respiratory disease segment is likely to hold a significant share over the forecast period. Based on the route of administration, the market is segmented into the nasal inhalable drug and mouth inhalable drugs. The mouth segment is likely to contribute a significant share over the forecast period.

A full report of US Inhalable Drugs Market Is available at https://www.omrglobal.com/industry-reports/us-inhalable-drugs-market

US Inhalable Drugs Market Segmentation

By Applications

Respiratory Diseases

Non- Respiratory Diseases

By Route of Administration

Nasal

Mouth

Competitive Lanscape

AstraZeneca Plc

AptarGroup, Inc.

Bausch Health Companies Inc.

Boehringer Ingelheim International GmbH

GlaxoSmithKline Plc

Johnson & Johnson Services Inc.

Merck & Co., Inc.

Pfizer Inc.

TFF Pharmaceuticals, Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-inhalable-drugs-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404